"Key Drivers Impacting Executive Summary Ablation Devices Market Size and Share
The global ablation devices market size was valued at USD 10.65 billion in 2024 and is expected to reach USD 24.98 billion by 2032, at a CAGR of 11.25% during the forecast periodThis growth is driven by factors such as the rising incidence of chronic diseases, increasing demand for minimally invasive...
"Key Drivers Impacting Executive Summary Asia-Pacific Ablation Devices Market Size and Share
The Asia-Pacific ablation devices market size was valued at USD 2.38 billion in 2024 and is expected to reach USD 5.29 billion by 2032, at a CAGR of 10.52% during the forecast periodThe market growth is largely fueled by the increasing prevalence of chronic diseases, particularly cardiac...
According to a newly published market research report by 24LifeSciences, global glycated hemoglobin testing market was valued at USD 322 million in 2024 and is projected to reach USD 530 million by 2031, growing at a compound annual growth rate (CAGR) of 7.6% during the forecast period 2025-2031.
Glycated hemoglobin (HbA1c) testing serves as the gold standard for diabetes management...
English
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek